Search Results - "von Garlen, S."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile by Merz, J., Nettesheim, A., von Garlen, S., Albrecht, P., Saller, B. S., Engelmann, J., Hertle, L., Schäfer, I., Dimanski, D., König, S., Karnbrock, L., Bulatova, K., Peikert, A., Hoppe, N., Hilgendorf, I., von zur Mühlen, C., Wolf, D., Groß, O., Bode, C., Zirlik, A., Stachon, P.

    Published in Purinergic signalling (01-09-2021)
    “…Extracellular nucleotides act as danger signals that orchestrate inflammation by purinergic receptor activation. The expression pattern of different purinergic…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Deficiency of the purinergic receptor P2X4 limits atherosclerosis in mice by Koenig, S, Peikert, A, Merz, J, Rofa, K, Schaefer, I, Dimanski, D, Karnbrock, L, Von Garlen, S, Aleid, R, Bulatova, K, Hoppe, N, Bode, C, Zirlik, A, Stachon, P

    Published in European heart journal (01-11-2020)
    “…Abstract Introduction Extracellular nucleotides like ATP promote inflammation as danger signals in various chronic diseases via purinergic receptors. In our…”
    Get full text
    Journal Article
  4. 4

    Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome of metabolic syndrome in mice by Merz, J, Rofa, K, Karnbrock, L, Von Garlen, S, Dimanski, D, Koenig, S, Bulatova, K, Schaefer, I, Peikert, A, Albrecht, P, Hoppe, N, Bode, C, Zirlik, A, Stachon, P

    Published in European heart journal (01-11-2020)
    “…Abstract   Metabolic syndrome (MetS) clusters the main risk factors for cardiovascular diseases (CVDs) and endocrine dysfunction. The pathomechanism of MetS is…”
    Get full text
    Journal Article